William R. Greco

5.6k total citations · 1 hit paper
82 papers, 4.5k citations indexed

About

William R. Greco is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William R. Greco has authored 82 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 22 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William R. Greco's work include Drug Transport and Resistance Mechanisms (11 papers), Photodynamic Therapy Research Studies (11 papers) and Nanoplatforms for cancer theranostics (8 papers). William R. Greco is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Photodynamic Therapy Research Studies (11 papers) and Nanoplatforms for cancer theranostics (8 papers). William R. Greco collaborates with scholars based in United States, France and Germany. William R. Greco's co-authors include Giangiacomo Bravo, Youcef M. Rustum, David A. Bellnier, Harry K. Slocum, Lurine A. Vaughan, Barbara W. Henderson, Thomas J. Dougherty, Allan R. Oseroff, Maire Hakala and Oskar S. Frankfurt and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

William R. Greco

82 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The search for synergy: a critical review from a response surface perspective.

1995 1.1k citations William R. Greco, Giangiacomo Bravo et al. Pharmacological Reviews profile →

Peers

Countries citing papers authored by William R. Greco

Since Specialization

Citations

This map shows the geographic impact of William R. Greco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Greco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Greco more than expected).

Fields of papers citing papers by William R. Greco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William R. Greco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Greco. The network helps show where William R. Greco may publish in the future.

Co-authorship network of co-authors of William R. Greco

This figure shows the co-authorship network connecting the top 25 collaborators of William R. Greco. A scholar is included among the top collaborators of William R. Greco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William R. Greco. William R. Greco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	D-optimal designs for parameter estimation for indirect pharmacodynamic response models 2009 ·Journal of Pharmacokinetics and Pharmacodynamics ·(unknown), Wojciech Krzyżański, William J. Jusko, William R. Greco	7
2	Rapamycin overcomes multidrug resistance (MDR) mediated by P-glycoprotein (Pgp), Multidrug Resistance Protein-1 (MRP-1), Breast Cancer Resistance Protein (BCRP) and Lung Resistance Protein (LRP) and synergizes with substrate drugs in MDR cells. 2006 ·Cancer Research ·Attaphol Pawarode, Hans Minderman, Kieran L. O’Loughlin, William R. Greco, Maria R. Baer	3
3	Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells 2006 ·Cancer Chemotherapy and Pharmacology ·(unknown), Suzanne Hector, William R. Greco, Kimberly Clark, Lesleyann Hawthorn, Carl W. Porter, Lakshmi Pendyala	21
4	Expression of Genes Related to Activity of Oxaliplatin and 5-Fluorouracil in Endoscopic Biopsies of Primary Esophageal Cancer in Patients Receiving Oxaliplatin, 5-Flourouracil and Radiation: Characterization and Exploratory Analysis with Survival 2006 ·Journal of Chemotherapy ·Lawrence Leichman, David Lawrence, Cynthia G. Leichman, (unknown), Edna Nava, (unknown), Kimberly Clark, Nikhil I. Khushalani, (unknown), William R. Greco, Patrick F. Smith, Patrick J. Creaven, (unknown), Milind Javle, Lakshmi Pendyala	12
5	Efficacy of Lidocaine or Bupivacaine Combined With Ephedrine in Rat Sciatic Nerve Block 2006 ·Regional Anesthesia & Pain Medicine ·Yi‐Chuan Kau, (unknown), Antonella Zizza, David Zurakowski, William R. Greco, Ging Kuo Wang, Philipp Gerner	28
6	Clinical Pharmacokinetics of the PDT Photosensitizers Porfimer Sodium (Photofrin), 2‐[1‐Hexyloxyethyl]‐2‐Devinyl Pyropheophorbide‐a (Photochlor) and 5‐ALA‐Induced Protoporphyrin IX 2006 ·Lasers in Surgery and Medicine ·David A. Bellnier, William R. Greco, Gregory Loewen, Hector Nava, Allan R. Oseroff, Thomas J. Dougherty	75
7	Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy 2005 ·Cancer Chemotherapy and Pharmacology ·David A. Bellnier, William R. Greco, Hector Nava, Gregory Loewen, Allan R. Oseroff, Thomas J. Dougherty	88
8	Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia 2005 ·Cancer Chemotherapy and Pharmacology ·Hans Minderman, Kieran L. O’Loughlin, Patrick F. Smith, Lakshmi Pendyala, William R. Greco, (unknown), Laurie Ford, Meir Wetzler, Maria R. Baer	6
9	Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease‐free survival 2004 ·British Journal of Haematology ·Attaya Suvannasankha, Hans Minderman, Kieran L. O’Loughlin, Takeo Nakanishi, Laurie Ford, William R. Greco, Meir Wetzler, Douglas D. Ross, Maria R. Baer	48
10	Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. 2003 ·PubMed ·David A. Bellnier, William R. Greco, Gregory Loewen, Hector Nava, Allan R. Oseroff, Ravindra K. Pandey, Takaaki Tsuchida, Thomas J. Dougherty	112
11	A New Nonlinear Mixture Response Surface Paradigm for the Study of Synergism: A Three Drug Example 2003 ·Current Drug Metabolism ·Donald B. White, Harry K. Slocum, (unknown), (unknown), William R. Greco	39
12	Expression of the neural cell adhesion molecule CD56 is not associated with P-glycoprotein overexpression in core-binding factor acute myeloid leukemia 2003 ·Leukemia Research ·Attaya Suvannasankha, Hans Minderman, Kieran L. O’Loughlin, Sheila N.J. Sait, Carleton C. Stewart, William R. Greco, Maria R. Baer	3
13	Effects of Orally Active Taxanes on P-Glycoprotein Modulation and Colon and Breast Carcinoma Drug Resistance 2001 ·JNCI Journal of the National Cancer Institute ·(unknown), Iwao Ojima, Jean Veith, Paula Pera, (unknown), Fernando Cabral, A. Sharma, Peter M. Kanter, William R. Greco, Ralph J. Bernacki	74
14	Brain MR Imaging in the Evaluation of Chronic Headache in Patients without Other Neurologic Symptoms 2001 ·Academic Radiology ·Henry Z. Wang, (unknown), William R. Greco, William T. C. Yuh	55
15	Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. 2000 ·PubMed ·Barbara W. Henderson, Theresa M. Busch, Lurine A. Vaughan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David A. Bellnier, William R. Greco, Allan R. Oseroff	228
16	Time-lapse video reveals immediate heterogeneity and heritable damage among human ileocecal carcinoma HCT-8 cells treated with raltitrexed (ZD1694) 2000 ·Cytometry ·Harry K. Slocum, John Carmi Parsons, (unknown), Lori Broderick, Hans Minderman, (unknown), William R. Greco, Youcef M. Rustum	5
17	Folic acid-enhanced synergy for the combination of trimetrexate plus the glycinamide ribonucleotide formyltransferase inhibitor 4-[2-(2-Amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimidino[5,4,6][1,4]thiazin-6-yl)-(S)-ethyl]-2,5-thienoylamino-l-glutamic acid (AG2034) 1999 ·Biochemical Pharmacology ·Hélène M. Faessel, (unknown), Y M Rustum, William R. Greco	11
18	Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells 1997 ·Cancer Chemotherapy and Pharmacology ·(unknown), William R. Greco, Y M Rustum, (unknown)	28
19	The search for synergy: a critical review from a response surface perspective. breakdown → 1995 ·Pharmacological Reviews ·William R. Greco, Giangiacomo Bravo, (unknown)	1144
20	Correspondence re: W. R. Greco et al., Application of a New Approach for the Quantitation of Drug Synergism to the Combination of cis-Diamminedichloroplatinum and 1-β-d-Arabinofuranosylcytosine. Cancer Res., 50: 5318–5327, 1990.—Reply 1992 ·Cancer Research ·William R. Greco, Youcef M. Rustum	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact